Tim A Labeur

4PUBLICATIONS
22CO-AUTHORS
Predictive and prognostic markersMolecular targets
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (4)

|May 06, 2020
The value of sorafenib trough levels in patients with advanced hepatocellular carcinoma - a substudy of the SORAMIC trial.

Tim A Labeur, Quincy Hofsink, R Bart Takkenberg

|Oct 04, 2019
Improved survival prediction and comparison of prognostic models for patients with hepatocellular carcinoma treated with sorafenib.

Tim A Labeur, Sarah Berhane, Julien Edeline

|Jun 27, 2018
Are we SHARP enough? The importance of adequate patient selection in sorafenib treatment for hepatocellular carcinoma.

Tim A Labeur, David W G Ten Cate, R Bart Takkenberg

Pageof 1